UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy

Head & neck, 2020-08, Vol.42 (8), p.2030-2038

2020

Volltextzugriff (PDF)

Real‐world treatment patterns of metastatic non‐small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.159-169

2023

Volltextzugriff (PDF)

Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13415-13425

2023

Volltextzugriff (PDF)

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study

Hereditary cancer in clinical practice, 2020-06, Vol.18 (1), p.13-13, Article 13

2020

Volltextzugriff (PDF)

Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States

Gynecologic oncology, 2018-11, Vol.151 (2), p.190-195

2018

Volltextzugriff (PDF)

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.289-289

2021

Volltextzugriff (PDF)

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.402-402

2022

Volltextzugriff (PDF)

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.102-102

2018

Volltextzugriff (PDF)

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.415-415

2018

Volltextzugriff (PDF)

HSR22-124: Real-World Outcomes Among Patients With Stage IV Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer Treated With EGFR Tyrosine Kinase Inhibitors Versus Immunotherapy With or Without Chemotherapy in First-line Setting

Journal of the National Comprehensive Cancer Network, 2022-03, Vol.20 (3.5), p.HSR22-124

2022

Volltextzugriff (PDF)

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5574-5574

2017

Volltextzugriff (PDF)

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.281-281

2020

Volltextzugriff (PDF)

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.363-363

2019

Volltextzugriff (PDF)

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19345-e19345

2020

Volltextzugriff (PDF)

Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors

Journal of the National Comprehensive Cancer Network, 2024-01, Vol.22 (1D), p.e237072-9.e13

2024

Volltextzugriff (PDF)

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16032-e16032

2017

Volltextzugriff (PDF)

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.396-396

2017

Volltextzugriff (PDF)

A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children

The Pediatric infectious disease journal, 2017-12, Vol.36 (12), p.1129-1140

2017

Volltextzugriff (PDF)

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

Clinical genitourinary cancer, 2018-12, Vol.16 (6), p.e1171-e1179

2018

Volltextzugriff (PDF)

Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12537-e12537

2017

Volltextzugriff (PDF)

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13624-e13624

2018

Volltextzugriff (PDF)

Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma

Journal of comparative effectiveness research, 2020-09, Vol.9 (13), p.945-957

2020

Volltextzugriff (PDF)

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012

Journal of geriatric oncology, 2021-03, Vol.12 (2), p.298-304

2021

Volltextzugriff (PDF)

Disease Burden Associated With International Classification of Diseases 9 (ICD-9) Diagnosed Influenza and Related Complications in United States Children Aged 6–35 Months

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

How Medicare Part D Benefit Phases Affect Adherence with Evidence-Based Medications Following Acute Myocardial Infarction

Health services research, 2013-12, Vol.48 (6pt1), p.1960-1977

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy

Real‐world treatment patterns of metastatic non‐small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors

Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study

Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

HSR22-124: Real-World Outcomes Among Patients With Stage IV Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer Treated With EGFR Tyrosine Kinase Inhibitors Versus Immunotherapy With or Without Chemotherapy in First-line Setting

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients

Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012

Disease Burden Associated With International Classification of Diseases 9 (ICD-9) Diagnosed Influenza and Related Complications in United States Children Aged 6–35 Months

How Medicare Part D Benefit Phases Affect Adherence with Evidence-Based Medications Following Acute Myocardial Infarction

Aktive Filter

Suchergebnisse filtern